Home » Topics » Regulatory

Regulatory
RSS

Celebrex approved for ankylosing spondylitis

Aug. 3, 2005

Japanese approval for Finibax

July 29, 2005

New Adderall XR approval extends use to adolescents

July 26, 2005

Rozerem receives FDA approval for insomnia

July 26, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005

New approval for Topamax

July 5, 2005

Avelox approved for complicated skin and skin structure infections

July 1, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

Tygacil receives FDA approval

June 17, 2005

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.